InvestorsHub Logo
Followers 161
Posts 2881
Boards Moderated 1
Alias Born 02/13/2014

Re: None

Tuesday, 09/23/2014 11:39:45 AM

Tuesday, September 23, 2014 11:39:45 AM

Post# of 9201
Richmond, British Columbia--(Newsfile Corp. - September 23, 2014) - Verde Science, Inc., (OTCQB: VRCI) a Medical Marijuana Research and Development Company with particular expertise in Aeroponic Growing Systems for the production of pure, efficacious Medical Marajuana, is pleased to announce a Research and Development Alliance with a Mumbai, India based pharmaceutical company that has a record of significant success in the development of novel medical treatment compounds. This new relationship will allow Verde to launch immediately on its THC Pharmaceutical Development Program, and accelerate its R and D operations by about one year. Without this important alliance Verde would have experienced unnecessary delays as it waited for its Research and Development License in Canada. According to Harp Sangha, Verde's Chairman and CEO, "Now we can immediately access the vast treasure of our Indian partner's intellectual capital and tap into a highly educated organization of research scientists in a cost effective manner."

The researchers in India will be planning and executing a comprehensive research program which would not be possible for several months to a year in Canada due to the waiting period for obtaining a Canadian R and D license. They will also prepare protocols for clinical trials which can be conducted immediately in India and subsequently in Canada after Verde obtains its R and D license. The company plans to develop specific, custom formulations and novel delivery mechanisms for cannabinoid and THC based drugs for a variety of ailments such as chronic pain, inflammation, migraines, seizures related to epilepsy, nausea associated with cancer treatment, and numerous others.

"This new Research and Development Program with a focus on developing custom formulations for specific medical issues will firmly place Verde on the cutting edge of cannabinoid and THC technology in treating illness, and our association with our new Indian partner will enable us to become a clearing house for research into new applications for marijuana based treatments of a variety of illnesses. The Verde brand will be synonymous with innovation into natural based remedies for a variety of debilitating illnesses." stated Mr. Sangha.